Yazar "Bozkurt, Nuray" seçeneğine göre listele

Listeleniyor 1 - 2 / 2
  • Küçük Resim
    Öğe
    Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: Results of aggregate and individual patient data meta-analyses
    (LIPPINCOTT WILLIAMS & WILKINS, 2019) Ovadia, Caroline; Seed, Paul T.; Sklavounos, Alexandros; Geenes, Victoria; Di Illio, Chiara; Chambers, Jenny; Kohari, Katherine; Bacq, Yannick; Bozkurt, Nuray; Brun-Furrer, Romana; Bull, Laura; Estiú, Maria C.; Grymowicz, Monika; Günaydın, Berrin; Hague, William M.; Haslinger, Christian; Hu, Yayi; Kawakita, Tetsuya; Kebapcılar, Ayşe Gül; Kebapcılar, Levent; Kondrackienė, Jūratė; Koster, Maria P. H.; Kowalska-Kańka, Aneta; Kupčinskas, Limas; Lee, Richard H.; Locatelli, Anna; Macias, Rocio I. R.; Marschall, Hanns-Ulrich; Oudijk, Martijn A.; Raz, Yael; Rimon, Eli; Shan, Dan; Tribe, Rachel; Tripodi, Valeria; Abide, Çiğdem Yayla; Yenidede, İlter; Thornton, Jim G.; Chappell, Lucy C.; Williamson, Catherine; Shao, Yong
    Intrahepatic cholestasis of pregnancy (ICP) affects less than 0.1% to 0.2% of pregnant women. It is diagnosed in women with gestational pruritus and increased serum bile acids and can be complicated by preterm labor, fetal asphyxia, meconium-stained amniotic fluid, and stillbirth.
  • Küçük Resim Yok
    Öğe
    Effect of luteal phase support after ovulation induction and intrauterine insemination
    (TAYLOR & FRANCIS LTD, 2014) Öktem, Mesut; Altınkaya, S. Özlem; Yımaz, Setenay Arzu; Bozkurt, Nuray; Erdem, Mehmet; Erdem, Ahmet; Gümüşlü, Seyhan
    Objective: This study aimed to evaluate the effect of luteal phase support on clinical pregnancy and live birth rates after ovulation induction and intrauterine insemination (IUI). Methods: 579 cycles from 2010 to 2013 were retrospectively evaluated. Ovarian stimulation was performed with gonadotropins, and rHCG was used for ovulation triggering. All patients received IUI. 451 cycles were supported by receiving vaginal micronized progesterone capsules (142 cycles) or vaginal progesterone gel (309 cycles) whereas 128 cycles were not supported. Results: Clinical pregnancy (20.6 versus 9.4%; p = 0.004) and live birth rates (14 versus 7%; p = 0.036) were higher for supported group than for unsupported group. Progesterone gel and micronized progesterone subgroups achieved similar clinical pregnancy and live birth rates (21.4 versus 19%, p = 0.567 and 14.2 versus 13.4%, p = 0.807; respectively). Conclusions: Luteal phase support improved the success of IUI cycles affecting both clinical pregnancy and live birth rates when gonadotropins were used for ovulation induction. The use of vaginal progesterone gel or micronized progesterone significantly improves clinical pregnancy rates. The live birth rates were higher in the progesterone gel group, but were similar in the micronized progesterone group compared to the unsupported group.